Abstract
We analyzed the usefulness of initial or recurrent treatment of temozolomide (TMZ) in pediatric high-grade gliomas (HGGs). Between 2002 and 2010, we performed surgery on 35 patients with 17 glioblastomas, 14 anaplastic astrocytomas, 3 anaplastic oligodendrogliomas, and 1 anaplastic oligoastrocytoma. The male-to-female ratio was 21:14, and the median age was 13 years (range, 3-18 years). The mean follow-up period was 15.9 (± 1.8) months. As the TMZ treatment, 22 patients received the initial treatment and 13 patients at recurrence. We analyzed the prognostic significance of TMZ treatment, tumor location, extent of removal, pathology, and recurrence pattern. The median progression-free survival (PFS) and overall survival (OS) were 9.7 (± 1.4) and 17.8 (± 2.5) months, respectively. Based on univariate analysis, the median PFS was 9.9 (± 1.6) months in the tumors located in the cerebral hemisphere and 5.6 (± 1.3) months in the diencephalon (p = 0.03). Median PFS was 12.5 (± 1.7) months in the initial treatment and 6.8 (±0.8) months in the recurrent treatment (p = 0.03). The median OS was 14.9 (± 2.3) months in glioblastomas and 24.4 (± 4.1) months in tumors with an anaplastic pathology (p = 0.01). The median OS was 12.1 (± 3.7) mon...Continue Reading
References
Jul 1, 1976·International Journal of Radiation Oncology, Biology, Physics·O M Salazar, P Rubin
Dec 1, 1978·Cancer·S S Erlich, R L Davis
Dec 1, 1980·Annals of Neurology·W A YungW R Shapiro
Apr 1, 1982·Neurosurgery·M SalcmanE Montgomery
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L FinlayM Tefft
May 1, 1993·Journal of Neurosurgery·B C DevauxP J Kelly
Dec 22, 1999·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·J L Finlay, J H Wisoff
Apr 9, 2002·Lancet·L A Stewart
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L S LashfordUNKNOWN United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study
Apr 5, 2003·Journal of Neuro-oncology·Ryuta SaitoTakashi Yoshimoto
Jul 22, 2004·British Journal of Cancer·A C VerschuurG Vassal
Aug 18, 2004·Toxicology and Applied Pharmacology·Rachel Tobias Baldwin, Susan Preston-Martin
Feb 25, 2005·Neurosurgical Focus·Mandeep S Tamber, James T Rutka
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Nov 18, 2005·Journal of Neuro-oncology·A RuggieroR Riccardi
Feb 10, 2006·Cancer Investigation·Alberto Broniscer
Mar 28, 2006·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Giuseppe BaroneRiccardo Riccardi
May 29, 2007·Journal of Neuro-oncology·Sucheta J VaidyaEric Bouffet
Aug 3, 2010·Journal of Neurosurgery. Pediatrics·Kyung Sun SongSeung-Ki Kim
Feb 23, 2011·Neuro-oncology·Kenneth J CohenRichard L Heideman
Citations
Nov 6, 2015·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Marina NikitovićIvana Mišković
Dec 19, 2015·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Gozde YaziciMurat Gurkaynak
Nov 5, 2014·Journal of Neuro-oncology·Tae-Young JungSeung-Ki Kim
May 31, 2017·Cancer Control : Journal of the Moffitt Cancer Center·Sajeel ChowdharyMarc C Chamberlain
Feb 16, 2019·BMJ Case Reports·Yasmin AghajanJohn Ross Crawford